Evidence map›Paper›PMID 37895235›Full record

ReviewGenes2023

The Role of IgLON Cell Adhesion Molecules in Neurodegenerative Diseases.

Marco Salluzzo, Clara Vianello, Sandra Abdullatef, Roberto Rimondini, Giovanni Piccoli, Lucia Carboni

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Downregulation ofFrontiers in oncology · 2025
    Article
  10. Article
  11. IgLON5-IgG: Innocent Bystander or Perpetrator?International journal of molecular sciences · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Marco SalluzzoDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.ORCID 0000-0003-0855-4940
Clara VianelloDepartment of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.
Sandra AbdullatefDepartment of Cellular, Computational and Integrative Biology, University of Trento, 38123 Trento, Italy.
Roberto RimondiniDepartment of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.ORCID 0000-0003-4099-513X
Giovanni PiccoliDepartment of Cellular, Computational and Integrative Biology, University of Trento, 38123 Trento, Italy.
Lucia CarboniDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.ORCID 0000-0001-9335-3312
University of Bologna · ITUniversity of Trento · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the brain, cell adhesion molecules (CAMs) are critical for neurite outgrowth, axonal fasciculation, neuronal survival and migration, and synapse formation and maintenance. Among CAMs, the IgLON family comprises five members: Opioid Binding Protein/Cell Adhesion Molecule Like (OPCML or OBCAM), Limbic System Associated Membrane Protein (LSAMP), neurotrimin (NTM), Neuronal Growth Regulator 1 (NEGR1), and IgLON5. IgLONs exhibit three N-terminal C2 immunoglobulin domains; several glycosylation sites; and a glycosylphosphatidylinositol anchoring to the membrane. Interactions as homo- or heterodimers in

Indexed as

Neurodegenerative DiseasesBrainCell Adhesion MoleculesCell Adhesion Molecules, NeuronalGPI-Linked ProteinsHumansImmunoglobulinsNeuronsCell Adhesion MoleculesCell Adhesion Molecules, NeuronalGPI-Linked ProteinsIgLON5 protein, humanImmunoglobulinsOPCML protein, humanAlzheimer’s diseaseHuntington’s diseaseIgLON5LSAMPNEGR1NEUROTRIMINNiemann-Pick diseaseOPCMLpsychiatric disordersSynucleinopathies

Identifiers

PMID37895235
PMCPMC10606101
OpenAlexW4387120253

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.